Atlas FDA

EMBLEM subcutaneous implantable cardioverter defibrillation (S-ICD) Programmer, EMBLEM Pulse Generator (PG)

FDA premarket approval P110042/S164 · decided 2021-12-17

Approval details

PMA number
P110042
Supplement
S164
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
EMBLEM subcutaneous implantable cardioverter defibrillation (S-ICD) Programmer, EMBLEM Pulse Generator (PG)
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
Boston Scientific Corporation
Date received
2021-09-30
Decision date
2021-12-17
Days to decision
78 days
Decision code
APPR
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
St Paul, MN
Statement
Approval for software changes for the EMBLEM S-ICD and Programmer SW Application Models 2877 and 3877, and firmware changes for the EMBLEM Pulse Generator.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27